和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688238 和元生物

已收盘 07-22 15:00:00

{"stockData":{"symbol":"688238","market":"SH","secType":"STK","nameCN":"和元生物","latestPrice":7.43,"timestamp":1753167600000,"preClose":7.52,"halted":0,"volume":17127646,"delay":0,"changeRate":-0.012,"floatShares":641000000,"shares":649000000,"eps":-0.5225,"marketStatus":"已收盘","change":-0.09,"latestTime":"07-22 15:00:00","open":7.47,"high":7.64,"low":7.4,"amount":129000000,"amplitude":0.0319,"askPrice":7.44,"askSize":1040,"bidPrice":7.43,"bidSize":442,"shortable":0,"etf":0,"ttmEps":-0.5225,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753234200000},"marketStatusCode":5,"adr":0,"adjPreClose":7.52,"symbolType":"stock_kcb","openAndCloseTimeList":[[1753147800000,1753155000000],[1753160400000,1753167600000]],"highLimit":8.27,"lowLimit":6.77,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":649036700,"isCdr":false,"pbRate":2.97,"roa":"--","roe":"--","epsLYR":-0.497,"committee":-0.084451,"marketValue":4822000000,"turnoverRate":0.0267,"status":1,"afterMarket":{"amount":0,"volume":0,"close":7.43,"buyVolume":0,"sellVolume":0,"time":1753169638018,"indexStatus":"已收盘 07-22 15:30:00","preClose":7.52},"floatMarketCap":4764000000},"requestUrl":"/m/hq/s/688238","defaultTab":"news","newsList":[{"id":"2552172864","title":"每周股票复盘：和元生物（688238）2025年第三次临时股东会通过三项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2552172864","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552172864?lang=zh_cn&edition=full","pubTime":"2025-07-20 05:06","pubTimestamp":1752959176,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘，和元生物报收于7.3元，较上周的7.18元上涨1.67%。和元生物技术（上海）股份有限公司发布了关于公司2025年限制性股票激励计划内幕信息知情人及激励对象买卖公司股票情况的自查报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000001239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2551194293","title":"和元生物股价下跌3.29% 临时股东大会明日召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2551194293","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551194293?lang=zh_cn&edition=full","pubTime":"2025-07-16 03:36","pubTimestamp":1752608184,"startTime":"0","endTime":"0","summary":"截至2025年7月15日收盘，和元生物股价报7.05元，较前一交易日下跌0.24元，跌幅3.29%。当日成交量为26.23万手，成交额达1.84亿元。和元生物属于医疗服务板块，专注于基因治疗领域，业务涵盖CAR-T细胞疗法、CRO及免疫治疗等方向。公司总部位于上海，致力于为生物医药研发提供技术支持。消息面上，和元生物将于7月16日召开2025年第三次临时股东大会，审议限制性股票激励计划及相关议案。资金方面，7月15日主力资金净流出4757.25万元。风险提示：股市有风险，投资需谨慎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071603444297a76ea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071603444297a76ea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2551137710","title":"和元生物股价下跌5.08% 板块轮动加剧资金分歧","url":"https://stock-news.laohu8.com/highlight/detail?id=2551137710","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551137710?lang=zh_cn&edition=full","pubTime":"2025-07-15 10:11","pubTimestamp":1752545483,"startTime":"0","endTime":"0","summary":"和元生物股价大幅下跌，最新价6.92元，跌幅5.08%。资金分歧与板块轮动共振和元生物近期股价波动与资金面高频切换密切相关。截至7月14日，该股单日主力资金净流入369.39万元，扭转前一交易日837.3万元净流出态势，反映短期市场情绪反复。技术壁垒与产能爬坡定调估值作为基因治疗CDMO/CRO领域核心企业，和元生物技术平台获行业认可，2024年该业务收入占比达89%。政策端持续释放红利，2025年前五月创新药对外授权交易额达455亿美元，行业长期增长动能明确。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715101134a44b1bdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715101134a44b1bdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2550693988","title":"CRO概念盘中拉升，和元生物涨7.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550693988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550693988?lang=zh_cn&edition=full","pubTime":"2025-07-10 10:05","pubTimestamp":1752113131,"startTime":"0","endTime":"0","summary":"07月10日，CRO概念盘中拉升，截至10点05分，CRO概念整体指数上涨1.04%，报500.440点。从个股上来看，该概念的成分股中，和元生物涨7.75%，凯莱英、宣泰医药、义翘神州涨幅居前。从资金上来看，截止发稿，CRO概念主力净流入为-44.59万，其中药明康德受到资金热捧，主力净流入4372.15万；拉长时间线来看，该板块近20日主力资金净流入-37.36亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710100531a6a07f88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710100531a6a07f88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238","603259"],"gpt_icon":0},{"id":"2549956708","title":"和元生物涨5.13% 板块轮动与资金博弈共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2549956708","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549956708?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:39","pubTimestamp":1751938779,"startTime":"0","endTime":"0","summary":"和元生物股价大幅上涨，最新价6.76元，涨跌幅为5.13%。资金博弈与板块轮动共振近期和元生物股价波动与主力资金高频腾挪密切相关。截至7月7日，该股连续两个交易日主力资金净流出936.7万元，反映部分投资者对短期走势持谨慎态度。同期医药生物板块整体承压，而半导体、消费电子等热点板块单日吸金超53亿元，形成显著虹吸效应。政策端，2025年前五月创新药对外授权交易额达455亿美元，行业β效应逐步显现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708093943a69bf932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708093943a69bf932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2548003983","title":"和元生物：第一期员工持股计划股票出售完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2548003983","media":"格隆汇资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548003983?lang=zh_cn&edition=full","pubTime":"2025-07-01 18:26","pubTimestamp":1751365567,"startTime":"0","endTime":"0","summary":"格隆汇7月1日丨和元生物(688238.SH)公布，第一期员工持股计划（以下简称“本次员工持股计划”）所持有的公司股票已全部出售完毕。截至本公告披露日，本次员工持股计划持有的公司股票5,508,413股已于锁定期届满后通过集中竞价交易方式全部出售完毕，所持有的资产均为货币性资产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070118261395326d48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070118261395326d48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2548074820","title":"和元生物：积极探索多样化的资本运作方式助力公司持续发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2548074820","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548074820?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:39","pubTimestamp":1751359142,"startTime":"0","endTime":"0","summary":"有投资者向和元生物提问， 董秘你好，请问贵司什么时候增发？公司回答表示，尊敬的投资者，您好。公司将根据企业战略规划和发展目标，结合业务特点、技术创新、资金状况等因素，积极探索多样化的资本运作方式，助力公司持续发展。如公司未来有相关计划，将严格按照监管要求及时履行信息披露义务。感谢您对公司的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701164557a7280762&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701164557a7280762&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2548079239","title":"和元生物：细胞和基因治疗赛道前景广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=2548079239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548079239?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:36","pubTimestamp":1751358975,"startTime":"0","endTime":"0","summary":"从国内看，目前我国细胞与基因治疗产业还比较薄弱。市场规模方面，2024年，我国细胞与基因治疗市场规模已超80亿元。随着国内细胞与基因治疗临床试验的大量开展、产品陆续预期获批上市，预计2025年我国细胞和基因治疗市场规模有望达到186.31亿元。以上此仅代表公司对于细胞与基因治疗行业总体发展趋势的认识和看法，敬请投资者关注行业最新动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100027289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2548713120","title":"和元生物：和元和美业务合作方主要为布局大健康领域的企业及医疗机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2548713120","media":"互动易","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548713120?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:24","pubTimestamp":1751358241,"startTime":"0","endTime":"0","summary":"有投资者向和元生物提问， 董秘你好，和元和美的护肤产品在哪购买？和元和美的业务合作方主要为布局大健康领域的企业及医疗机构等，目前已与赛希尔生物、禾普疼痛、静和医疗、中国人民保险等多家企业开展全面合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701162803a4c8825e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701162803a4c8825e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2548310071","title":"和元生物：再生医学业务尚处于市场推广投入期","url":"https://stock-news.laohu8.com/highlight/detail?id=2548310071","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548310071?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:24","pubTimestamp":1751358240,"startTime":"0","endTime":"0","summary":"有投资者向和元生物提问， 请问公司和元和美的产品是否已经进入成熟市场，是否产生利润，市场前沿价值分析，和占有市场份额。2024年4月公司投资设立全资子公司和元和美（上海）生物技术有限公司，2024年9月和元和美成立“再生医学中心”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701162554a727f96b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701162554a727f96b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2548071343","title":"和元生物：不会有收购和元艾迪斯股权并入报表的计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2548071343","media":"互动易","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548071343?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:24","pubTimestamp":1751358240,"startTime":"0","endTime":"0","summary":"有投资者向和元生物提问， 请问贵司有收购和元艾迪斯股权并入报表的计划吗？公司回答表示，尊敬的投资者，您好。2020年度，公司为了进一步聚焦细胞和基因治疗CRO/CDMO业务，剥离了与新药开发相关的业务，公司仅保留了对和元艾迪斯的17.18%的股份，因此不会有收购和元艾迪斯股权并入报表的计划。感谢您对公司的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701162601a727f985&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701162601a727f985&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2546360749","title":"和元生物：将于2025年7月16日召开2025年第三次临时股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2546360749","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546360749?lang=zh_cn&edition=full","pubTime":"2025-06-27 21:04","pubTimestamp":1751029479,"startTime":"0","endTime":"0","summary":"和元生物公告，公司董事会决定于2025年7月16日召开第三次临时股东大会，会议将采用现场与网络投票结合的方式进行表决。会议地点位于上海市浦东新区 国际医学 园区紫萍路908弄19号，主要审议《关于公司2025年限制性股票激励计划（草案）及其摘要的议案》等三项议案。参会股东需在2025年7月9日前完成登记，关联股东应回避相关议案的表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627210909a4c14fdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627210909a4c14fdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2546749393","title":"和元生物：潘讴东当选董事长并兼任总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2546749393","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546749393?lang=zh_cn&edition=full","pubTime":"2025-06-27 20:51","pubTimestamp":1751028676,"startTime":"0","endTime":"0","summary":"和元生物发布公告，2025年6月27日，召开第二次临时股东大会，选举产生了公司第四届董事会，包括4名非独立董事和4名独立董事，以及1名职工代表董事，任期为三年。在董事长选举中，潘讴东被选为董事长，董事会的专门委员会成员也进行了相应的选举。2025年一季度，和元生物实现收入5285万元，归母净利润-5948万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062720512297916748&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062720512297916748&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2546274546","title":"和元生物：拟推374.54万股限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2546274546","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546274546?lang=zh_cn&edition=full","pubTime":"2025-06-27 20:31","pubTimestamp":1751027480,"startTime":"0","endTime":"0","summary":"格隆汇6月27日丨和元生物(688238.SH)公布2025年限制性股票激励计划，公司2025年限制性股票激励计划拟授予激励对象的限制性股票数量为374.54万股，约占本激励计划草案公告日公司股本总额的0.58%。其中，首次授予限制性股票299.64万股，约占本激励计划草案公告日公司股本总额的0.46%，占本激励计划拟授予限制性股票总数的80.00%；预留部分74.9万股，约占本激励计划草案公告日公司股本总额的0.12%，预留部分占本激励计划拟授予限制性股票总数的20.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627203128979161e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627203128979161e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2546783097","title":"和元生物06月26日遭主力抛售297.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546783097","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546783097?lang=zh_cn&edition=full","pubTime":"2025-06-26 15:21","pubTimestamp":1750922487,"startTime":"0","endTime":"0","summary":"06月26日, 和元生物股价跌1.84%，报收5.88元，成交金额5914.5万元，换手率1.56%，振幅2.17%，量比1.19。和元生物今日主力资金净流出297.4万元，连续4日净流出，上一交易日主力净流出194.2万元。该股近5个交易日上涨0.17%，主力资金累计净流出1283.9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出8225.8万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626165941a4bedd74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626165941a4bedd74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2546518218","title":"和元生物06月25日遭主力抛售194.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546518218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546518218?lang=zh_cn&edition=full","pubTime":"2025-06-25 15:20","pubTimestamp":1750836052,"startTime":"0","endTime":"0","summary":"06月25日，和元生物股价收平报5.99元，成交金额4984.8万元，换手率1.31%，振幅1.84%，量比0.99。和元生物今日主力资金净流出194.2万元，连续3日净流出，上一交易日主力净流出938.3万元。该股近5个交易日上涨1.87%，主力资金累计净流出924.5万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出9056.3万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625171137a4bd0814&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625171137a4bd0814&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2545480659","title":"CRO与CDMO的那些合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2545480659","media":"药事纵横","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545480659?lang=zh_cn&edition=full","pubTime":"2025-06-22 08:02","pubTimestamp":1750550540,"startTime":"0","endTime":"0","summary":"目前，国内CRO有药明康德、康龙化成、泰格医药、昭衍新药、美迪西、康维讯生物、泰格医药等公司，而CDMO有药明生物、药明合联、九洲药业、康龙化成、博腾股份、和元生物、臻格生物等公司，以下盘点了 CRO 与 CDMO 的典型合作案例。结语在生物药行业蓬勃发展但竞争激烈的当下，CRO 与 CDMO 的合作是推动行业进步的重要力量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250622081132a7168ed9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250622081132a7168ed9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2544180858","title":"医疗服务行业盘中跳水，和元生物平盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2544180858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544180858?lang=zh_cn&edition=full","pubTime":"2025-06-19 09:47","pubTimestamp":1750297671,"startTime":"0","endTime":"0","summary":"06月19日，医疗服务行业盘中跳水，截至09点47分，医疗服务行业整体指数下跌0.52%，报5236.770点。从个股上来看，该行业的成分股中，和元生物平盘，跌幅居前。从资金上来看，截止发稿，医疗服务行业主力净流入为2.38亿，其中创新医疗受到资金热捧，主力净流入3.05亿；拉长时间线来看，该板块近20日主力资金净流入-42.91亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619094751a7118718&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619094751a7118718&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2544318713","title":"CRO概念盘中拉升，和元生物涨0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544318713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544318713?lang=zh_cn&edition=full","pubTime":"2025-06-19 09:37","pubTimestamp":1750297024,"startTime":"0","endTime":"0","summary":"06月19日，CRO概念盘中拉升，截至09点37分，CRO概念整体指数上涨0.53%，报446.670点。从个股上来看，该概念的成分股中，和元生物涨0.51%，泰格医药、XD九洲药、皓元医药涨幅居前。从资金上来看，截止发稿，CRO概念主力净流入为-2416.30万，其中药明康德受到资金热捧，主力净流入718.80万；拉长时间线来看，该板块近20日主力资金净流入-40.65亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619093704a4b1909c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619093704a4b1909c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","LU1997245094.SGD","LU1969619763.USD","LU2495084118.USD","LU2328871848.SGD","603456","688238","LU0456842615.SGD","LU1997245177.USD","LU1997244956.HKD","603259","BK0216"],"gpt_icon":0},{"id":"2544922175","title":"和元生物06月18日遭主力抛售587.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544922175","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544922175?lang=zh_cn&edition=full","pubTime":"2025-06-18 15:21","pubTimestamp":1750231287,"startTime":"0","endTime":"0","summary":"06月18日, 和元生物股价跌1.51%，报收5.88元，成交金额5087.3万元，换手率1.34%，振幅2.35%，量比0.62。和元生物今日主力资金净流出587.9万元，连续7日净流出，上一交易日主力净流出126.6万元。该股近5个交易日下跌6.22%，主力资金累计净流出3804.3万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出5755.0万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618170942a4b034e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618170942a4b034e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753223266937,"stockEarnings":[{"period":"1week","weight":0.0539},{"period":"1month","weight":0.2701},{"period":"3month","weight":0.2744},{"period":"6month","weight":0.6258},{"period":"1year","weight":0.6223},{"period":"ytd","weight":0.504}],"compareEarnings":[{"period":"1week","weight":0.0219},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.0866},{"period":"6month","weight":0.1089},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0686}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"和元生物技术(上海)股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"11799人(较上一季度减少4.10%)","perCapita":"54338股","listingDate":"2022-03-22","address":"上海市浦东新区国际医学园区紫萍路908弄19号楼","registeredCapital":"64903万元","survey":"　　和元生物技术(上海)股份有限公司是一家聚焦基因治疗领域的生物科技公司，专注于为基因治疗的基础研究提供基因治疗载体研制、基因功能研究等CRO服务，以及为基因药物的研发提供IND-CMC药学研究、临床样品GMP生产等CDMO服务。主要产品有基因治疗CRO、基因治疗CDMO、生物制剂、试剂。","listedPrice":13.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和元生物,688238,和元生物股票,和元生物股票老虎,和元生物股票老虎国际,和元生物行情,和元生物股票行情,和元生物股价,和元生物股市,和元生物股票价格,和元生物股票交易,和元生物股票购买,和元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}